aluates Reports

$ 0.0

Automative

Global CRISPR Nucleases Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-33S14159

Global CRISPR Nucleases Market Research Report 2023

BUY CHAPTERS

Global CRISPR Nucleases Market Research Report 2025

Code: QYRE-Auto-33S14159

Report

April 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher

TriLink BioTechnologies

Qiagen NV

Editas Medicine

Caribou Biosciences

CRISPR Therapeutics

Intellia Therapeutics Inc

Horizon Discovery Plc

Sigma-aldrich

GenScript

Integrated DNA Technologies

New England Biolabs

Origene Technologies

Aldevron

Takara Bio

CRISPR Nucleases Market

The global market for CRISPR Nucleases was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for CRISPR Nucleases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for CRISPR Nucleases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for CRISPR Nucleases in Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of CRISPR Nucleases include Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc, Sigma Aldrich, Genscript, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for CRISPR Nucleases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Nucleases.

The CRISPR Nucleases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR Nucleases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CRISPR Nucleases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CRISPR Nucleases Market Report

Report Metric	Details
Report Name	CRISPR Nucleases Market
Segment by Type	CRISPR Cas3 CRISPR Cas9 CRISPR Cas10 Others
Segment by Application	Biotechnology Companies Pharmaceutical Companies Academic Institutes Research and Development Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc, Sigma Aldrich, Genscript, Integrated DNA Technologies, New England Biolabs, Origene Technologies, Aldevron, Takara Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Nucleases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CRISPR Nucleases Market report?

Ans: The main players in the CRISPR Nucleases Market are Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc, Sigma Aldrich, Genscript, Integrated DNA Technologies, New England Biolabs, Origene Technologies, Aldevron, Takara Bio

What are the Application segmentation covered in the CRISPR Nucleases Market report?

Ans: The Applications covered in the CRISPR Nucleases Market report are Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes

What are the Type segmentation covered in the CRISPR Nucleases Market report?

Ans: The Types covered in the CRISPR Nucleases Market report are CRISPR Cas3, CRISPR Cas9, CRISPR Cas10, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CRISPR Nucleases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CRISPR Cas3

1.2.3 CRISPR Cas9

1.2.4 CRISPR Cas10

1.2.5 Others

1.3 Market by Application

1.3.1 Global CRISPR Nucleases Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Biotechnology Companies

1.3.3 Pharmaceutical Companies

1.3.4 Academic Institutes

1.3.5 Research and Development Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CRISPR Nucleases Market Perspective (2020-2031)

2.2 Global CRISPR Nucleases Growth Trends by Region

2.2.1 Global CRISPR Nucleases Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 CRISPR Nucleases Historic Market Size by Region (2020-2025)

2.2.3 CRISPR Nucleases Forecasted Market Size by Region (2026-2031)

2.3 CRISPR Nucleases Market Dynamics

2.3.1 CRISPR Nucleases Industry Trends

2.3.2 CRISPR Nucleases Market Drivers

2.3.3 CRISPR Nucleases Market Challenges

2.3.4 CRISPR Nucleases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CRISPR Nucleases Players by Revenue

3.1.1 Global Top CRISPR Nucleases Players by Revenue (2020-2025)

3.1.2 Global CRISPR Nucleases Revenue Market Share by Players (2020-2025)

3.2 Global CRISPR Nucleases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CRISPR Nucleases Revenue

3.4 Global CRISPR Nucleases Market Concentration Ratio

3.4.1 Global CRISPR Nucleases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CRISPR Nucleases Revenue in 2024

3.5 Global Key Players of CRISPR Nucleases Head office and Area Served

3.6 Global Key Players of CRISPR Nucleases, Product and Application

3.7 Global Key Players of CRISPR Nucleases, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR Nucleases Breakdown Data by Type

4.1 Global CRISPR Nucleases Historic Market Size by Type (2020-2025)

4.2 Global CRISPR Nucleases Forecasted Market Size by Type (2026-2031)

5 CRISPR Nucleases Breakdown Data by Application

5.1 Global CRISPR Nucleases Historic Market Size by Application (2020-2025)

5.2 Global CRISPR Nucleases Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America CRISPR Nucleases Market Size (2020-2031)

6.2 North America CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America CRISPR Nucleases Market Size by Country (2020-2025)

6.4 North America CRISPR Nucleases Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CRISPR Nucleases Market Size (2020-2031)

7.2 Europe CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe CRISPR Nucleases Market Size by Country (2020-2025)

7.4 Europe CRISPR Nucleases Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CRISPR Nucleases Market Size (2020-2031)

8.2 Asia-Pacific CRISPR Nucleases Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific CRISPR Nucleases Market Size by Region (2020-2025)

8.4 Asia-Pacific CRISPR Nucleases Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CRISPR Nucleases Market Size (2020-2031)

9.2 Latin America CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America CRISPR Nucleases Market Size by Country (2020-2025)

9.4 Latin America CRISPR Nucleases Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CRISPR Nucleases Market Size (2020-2031)

10.2 Middle East & Africa CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa CRISPR Nucleases Market Size by Country (2020-2025)

10.4 Middle East & Africa CRISPR Nucleases Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher

11.1.1 Thermo Fisher Company Details

11.1.2 Thermo Fisher Business Overview

11.1.3 Thermo Fisher CRISPR Nucleases Introduction

11.1.4 Thermo Fisher Revenue in CRISPR Nucleases Business (2020-2025)

11.1.5 Thermo Fisher Recent Development

11.2 TriLink BioTechnologies

11.2.1 TriLink BioTechnologies Company Details

11.2.2 TriLink BioTechnologies Business Overview

11.2.3 TriLink BioTechnologies CRISPR Nucleases Introduction

11.2.4 TriLink BioTechnologies Revenue in CRISPR Nucleases Business (2020-2025)

11.2.5 TriLink BioTechnologies Recent Development

11.3 Qiagen

11.3.1 Qiagen Company Details

11.3.2 Qiagen Business Overview

11.3.3 Qiagen CRISPR Nucleases Introduction

11.3.4 Qiagen Revenue in CRISPR Nucleases Business (2020-2025)

11.3.5 Qiagen Recent Development

11.4 Editas Medicine

11.4.1 Editas Medicine Company Details

11.4.2 Editas Medicine Business Overview

11.4.3 Editas Medicine CRISPR Nucleases Introduction

11.4.4 Editas Medicine Revenue in CRISPR Nucleases Business (2020-2025)

11.4.5 Editas Medicine Recent Development

11.5 Caribou Biosciences

11.5.1 Caribou Biosciences Company Details

11.5.2 Caribou Biosciences Business Overview

11.5.3 Caribou Biosciences CRISPR Nucleases Introduction

11.5.4 Caribou Biosciences Revenue in CRISPR Nucleases Business (2020-2025)

11.5.5 Caribou Biosciences Recent Development

11.6 CRISPR therapeutics

11.6.1 CRISPR therapeutics Company Details

11.6.2 CRISPR therapeutics Business Overview

11.6.3 CRISPR therapeutics CRISPR Nucleases Introduction

11.6.4 CRISPR therapeutics Revenue in CRISPR Nucleases Business (2020-2025)

11.6.5 CRISPR therapeutics Recent Development

11.7 Intellia therapeutics, Inc.

11.7.1 Intellia therapeutics, Inc. Company Details

11.7.2 Intellia therapeutics, Inc. Business Overview

11.7.3 Intellia therapeutics, Inc. CRISPR Nucleases Introduction

11.7.4 Intellia therapeutics, Inc. Revenue in CRISPR Nucleases Business (2020-2025)

11.7.5 Intellia therapeutics, Inc. Recent Development

11.8 Horizon Discovery Plc

11.8.1 Horizon Discovery Plc Company Details

11.8.2 Horizon Discovery Plc Business Overview

11.8.3 Horizon Discovery Plc CRISPR Nucleases Introduction

11.8.4 Horizon Discovery Plc Revenue in CRISPR Nucleases Business (2020-2025)

11.8.5 Horizon Discovery Plc Recent Development

11.9 Sigma Aldrich

11.9.1 Sigma Aldrich Company Details

11.9.2 Sigma Aldrich Business Overview

11.9.3 Sigma Aldrich CRISPR Nucleases Introduction

11.9.4 Sigma Aldrich Revenue in CRISPR Nucleases Business (2020-2025)

11.9.5 Sigma Aldrich Recent Development

11.10 Genscript

11.10.1 Genscript Company Details

11.10.2 Genscript Business Overview

11.10.3 Genscript CRISPR Nucleases Introduction

11.10.4 Genscript Revenue in CRISPR Nucleases Business (2020-2025)

11.10.5 Genscript Recent Development

11.11 Integrated DNA Technologies

11.11.1 Integrated DNA Technologies Company Details

11.11.2 Integrated DNA Technologies Business Overview

11.11.3 Integrated DNA Technologies CRISPR Nucleases Introduction

11.11.4 Integrated DNA Technologies Revenue in CRISPR Nucleases Business (2020-2025)

11.11.5 Integrated DNA Technologies Recent Development

11.12 New England Biolabs

11.12.1 New England Biolabs Company Details

11.12.2 New England Biolabs Business Overview

11.12.3 New England Biolabs CRISPR Nucleases Introduction

11.12.4 New England Biolabs Revenue in CRISPR Nucleases Business (2020-2025)

11.12.5 New England Biolabs Recent Development

11.13 Origene Technologies

11.13.1 Origene Technologies Company Details

11.13.2 Origene Technologies Business Overview

11.13.3 Origene Technologies CRISPR Nucleases Introduction

11.13.4 Origene Technologies Revenue in CRISPR Nucleases Business (2020-2025)

11.13.5 Origene Technologies Recent Development

11.14 Aldevron

11.14.1 Aldevron Company Details

11.14.2 Aldevron Business Overview

11.14.3 Aldevron CRISPR Nucleases Introduction

11.14.4 Aldevron Revenue in CRISPR Nucleases Business (2020-2025)

11.14.5 Aldevron Recent Development

11.15 Takara Bio

11.15.1 Takara Bio Company Details

11.15.2 Takara Bio Business Overview

11.15.3 Takara Bio CRISPR Nucleases Introduction

11.15.4 Takara Bio Revenue in CRISPR Nucleases Business (2020-2025)

11.15.5 Takara Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher

TriLink BioTechnologies

Qiagen NV

Editas Medicine

Caribou Biosciences

CRISPR Therapeutics

Intellia Therapeutics Inc

Horizon Discovery Plc

Sigma-aldrich

GenScript

Integrated DNA Technologies

New England Biolabs

Origene Technologies

Aldevron

Takara Bio

List of Tables

Table 1. Global CRISPR Nucleases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CRISPR Cas3

Table 3. Key Players of CRISPR Cas9

Table 4. Key Players of CRISPR Cas10

Table 5. Key Players of Others

Table 6. Global CRISPR Nucleases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global CRISPR Nucleases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global CRISPR Nucleases Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global CRISPR Nucleases Market Share by Region (2020-2025)

Table 10. Global CRISPR Nucleases Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global CRISPR Nucleases Market Share by Region (2026-2031)

Table 12. CRISPR Nucleases Market Trends

Table 13. CRISPR Nucleases Market Drivers

Table 14. CRISPR Nucleases Market Challenges

Table 15. CRISPR Nucleases Market Restraints

Table 16. Global CRISPR Nucleases Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global CRISPR Nucleases Market Share by Players (2020-2025)

Table 18. Global Top CRISPR Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Nucleases as of 2024)

Table 19. Ranking of Global Top CRISPR Nucleases Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by CRISPR Nucleases Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of CRISPR Nucleases, Headquarters and Area Served

Table 22. Global Key Players of CRISPR Nucleases, Product and Application

Table 23. Global Key Players of CRISPR Nucleases, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global CRISPR Nucleases Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global CRISPR Nucleases Revenue Market Share by Type (2020-2025)

Table 27. Global CRISPR Nucleases Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global CRISPR Nucleases Revenue Market Share by Type (2026-2031)

Table 29. Global CRISPR Nucleases Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global CRISPR Nucleases Revenue Market Share by Application (2020-2025)

Table 31. Global CRISPR Nucleases Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global CRISPR Nucleases Revenue Market Share by Application (2026-2031)

Table 33. North America CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific CRISPR Nucleases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific CRISPR Nucleases Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific CRISPR Nucleases Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)

Table 48. Thermo Fisher Company Details

Table 49. Thermo Fisher Business Overview

Table 50. Thermo Fisher CRISPR Nucleases Product

Table 51. Thermo Fisher Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 52. Thermo Fisher Recent Development

Table 53. TriLink BioTechnologies Company Details

Table 54. TriLink BioTechnologies Business Overview

Table 55. TriLink BioTechnologies CRISPR Nucleases Product

Table 56. TriLink BioTechnologies Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 57. TriLink BioTechnologies Recent Development

Table 58. Qiagen Company Details

Table 59. Qiagen Business Overview

Table 60. Qiagen CRISPR Nucleases Product

Table 61. Qiagen Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 62. Qiagen Recent Development

Table 63. Editas Medicine Company Details

Table 64. Editas Medicine Business Overview

Table 65. Editas Medicine CRISPR Nucleases Product

Table 66. Editas Medicine Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 67. Editas Medicine Recent Development

Table 68. Caribou Biosciences Company Details

Table 69. Caribou Biosciences Business Overview

Table 70. Caribou Biosciences CRISPR Nucleases Product

Table 71. Caribou Biosciences Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 72. Caribou Biosciences Recent Development

Table 73. CRISPR therapeutics Company Details

Table 74. CRISPR therapeutics Business Overview

Table 75. CRISPR therapeutics CRISPR Nucleases Product

Table 76. CRISPR therapeutics Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 77. CRISPR therapeutics Recent Development

Table 78. Intellia therapeutics, Inc. Company Details

Table 79. Intellia therapeutics, Inc. Business Overview

Table 80. Intellia therapeutics, Inc. CRISPR Nucleases Product

Table 81. Intellia therapeutics, Inc. Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 82. Intellia therapeutics, Inc. Recent Development

Table 83. Horizon Discovery Plc Company Details

Table 84. Horizon Discovery Plc Business Overview

Table 85. Horizon Discovery Plc CRISPR Nucleases Product

Table 86. Horizon Discovery Plc Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 87. Horizon Discovery Plc Recent Development

Table 88. Sigma Aldrich Company Details

Table 89. Sigma Aldrich Business Overview

Table 90. Sigma Aldrich CRISPR Nucleases Product

Table 91. Sigma Aldrich Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 92. Sigma Aldrich Recent Development

Table 93. Genscript Company Details

Table 94. Genscript Business Overview

Table 95. Genscript CRISPR Nucleases Product

Table 96. Genscript Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 97. Genscript Recent Development

Table 98. Integrated DNA Technologies Company Details

Table 99. Integrated DNA Technologies Business Overview

Table 100. Integrated DNA Technologies CRISPR Nucleases Product

Table 101. Integrated DNA Technologies Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 102. Integrated DNA Technologies Recent Development

Table 103. New England Biolabs Company Details

Table 104. New England Biolabs Business Overview

Table 105. New England Biolabs CRISPR Nucleases Product

Table 106. New England Biolabs Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 107. New England Biolabs Recent Development

Table 108. Origene Technologies Company Details

Table 109. Origene Technologies Business Overview

Table 110. Origene Technologies CRISPR Nucleases Product

Table 111. Origene Technologies Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 112. Origene Technologies Recent Development

Table 113. Aldevron Company Details

Table 114. Aldevron Business Overview

Table 115. Aldevron CRISPR Nucleases Product

Table 116. Aldevron Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 117. Aldevron Recent Development

Table 118. Takara Bio Company Details

Table 119. Takara Bio Business Overview

Table 120. Takara Bio CRISPR Nucleases Product

Table 121. Takara Bio Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)

Table 122. Takara Bio Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. CRISPR Nucleases Picture

Figure 2. Global CRISPR Nucleases Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global CRISPR Nucleases Market Share by Type: 2024 VS 2031

Figure 4. CRISPR Cas3 Features

Figure 5. CRISPR Cas9 Features

Figure 6. CRISPR Cas10 Features

Figure 7. Others Features

Figure 8. Global CRISPR Nucleases Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global CRISPR Nucleases Market Share by Application: 2024 VS 2031

Figure 10. Biotechnology Companies Case Studies

Figure 11. Pharmaceutical Companies Case Studies

Figure 12. Academic Institutes Case Studies

Figure 13. Research and Development Institutes Case Studies

Figure 14. CRISPR Nucleases Report Years Considered

Figure 15. Global CRISPR Nucleases Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global CRISPR Nucleases Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global CRISPR Nucleases Market Share by Region: 2024 VS 2031

Figure 18. Global CRISPR Nucleases Market Share by Players in 2024

Figure 19. Global Top CRISPR Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Nucleases as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by CRISPR Nucleases Revenue in 2024

Figure 21. North America CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America CRISPR Nucleases Market Share by Country (2020-2031)

Figure 23. United States CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe CRISPR Nucleases Market Share by Country (2020-2031)

Figure 27. Germany CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific CRISPR Nucleases Market Share by Region (2020-2031)

Figure 35. China CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America CRISPR Nucleases Market Share by Country (2020-2031)

Figure 43. Mexico CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa CRISPR Nucleases Market Share by Country (2020-2031)

Figure 47. Turkey CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Thermo Fisher Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 51. TriLink BioTechnologies Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 52. Qiagen Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 53. Editas Medicine Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 54. Caribou Biosciences Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 55. CRISPR therapeutics Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 56. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 57. Horizon Discovery Plc Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 58. Sigma Aldrich Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 59. Genscript Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 60. Integrated DNA Technologies Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 61. New England Biolabs Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 62. Origene Technologies Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 63. Aldevron Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 64. Takara Bio Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Crisper Related Nuclease Market Research Report 2024

Global Crispr Genomic Cure Market Research Report 2024

Global CRISPR PE Technology Market Research Report 2024

Global CRISPR Gene Editing Service Market Research Report 2025

Global CRISPR Cas9 Gene Editing Service Market Research Report 2025

Global Ultra Nuclease Market Research Report 2024

Global CRISPR Gene Detection and Diagnostic Market Research Report 2024

Global Gene Editing Therapy Market Research Report 2024

Global CRISPR Gene Testing and Diagnostics Market Research Report 2024

Global CRISPER associated Nucleases Market Research Report 2024

Global Cas Nuclease Market Research Report 2025

Global Genome Engineering Editing Market Research Report 2024

Global Cas9 Protein Market Research Report 2024

Global CAS9 Technology Market Research Report 2024

Global Totipotent Nuclease Market Research Report 2024

Global CRISPR associated Nucleases Market Research Report 2024

Global Genome Editing Techniques Market Research Report 2024

Global CRISPR Based Therapeutics Market Research Report 2024

Genome Editing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6W17226

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34V19460

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6C20013

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K19803

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions